img

Global Immunoglobulin G Antibody Therapeutics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immunoglobulin G Antibody Therapeutics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.

Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
Immunoglobulin G Antibody Therapeutics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immunoglobulin G Antibody Therapeutics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Autoimmune and Tumor are the major drivers for the industry.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immunoglobulin G Antibody Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
Segment by Type
IgG1
IgG4
Others

Segment by Application


Autoimmune
Tumor
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immunoglobulin G Antibody Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immunoglobulin G Antibody Therapeutics introduction, etc. Immunoglobulin G Antibody Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Immunoglobulin G Antibody Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Immunoglobulin G Antibody Therapeutics
1.1 Immunoglobulin G Antibody Therapeutics Market Overview
1.1.1 Immunoglobulin G Antibody Therapeutics Product Scope
1.1.2 Immunoglobulin G Antibody Therapeutics Market Status and Outlook
1.2 Global Immunoglobulin G Antibody Therapeutics Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Immunoglobulin G Antibody Therapeutics Market Size by Region (2024-2034)
1.4 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Region (2024-2024)
1.5 Global Immunoglobulin G Antibody Therapeutics Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
1.6.1 North America Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
1.6.2 Europe Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
1.6.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
1.6.4 Latin America Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
1.6.5 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size (2024-2034)
2 Immunoglobulin G Antibody Therapeutics Market by Type
2.1 Introduction
2.1.1 IgG1
2.1.2 IgG4
2.1.3 Others
2.2 Global Immunoglobulin G Antibody Therapeutics Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Type (2024-2024)
2.2.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Type (2024-2034)
3 Immunoglobulin G Antibody Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Autoimmune
3.1.2 Tumor
3.1.3 Others
3.2 Global Immunoglobulin G Antibody Therapeutics Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Immunoglobulin G Antibody Therapeutics Historic Market Size by Application (2024-2024)
3.2.2 Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue Breakdown by Application (2024-2034)
4 Immunoglobulin G Antibody Therapeutics Competition Analysis by Players
4.1 Global Immunoglobulin G Antibody Therapeutics Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2022)
4.3 Date of Key Players Enter into Immunoglobulin G Antibody Therapeutics Market
4.4 Global Top Players Immunoglobulin G Antibody Therapeutics Headquarters and Area Served
4.5 Key Players Immunoglobulin G Antibody Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Immunoglobulin G Antibody Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.1.4 Roche Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.1.5 Roche Recent Developments
5.2 Abbvie
5.2.1 Abbvie Profile
5.2.2 Abbvie Main Business
5.2.3 Abbvie Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.2.5 Abbvie Recent Developments
5.3 J & J
5.3.1 J & J Profile
5.3.2 J & J Main Business
5.3.3 J & J Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.3.4 J & J Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.5.4 Novartis Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.5.5 Novartis Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.6.4 Merck Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.6.5 Merck Recent Developments
5.7 Alexion Pharmaceuticals
5.7.1 Alexion Pharmaceuticals Profile
5.7.2 Alexion Pharmaceuticals Main Business
5.7.3 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.7.4 Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.7.5 Alexion Pharmaceuticals Recent Developments
5.8 Takeda
5.8.1 Takeda Profile
5.8.2 Takeda Main Business
5.8.3 Takeda Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.8.4 Takeda Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.8.5 Takeda Recent Developments
5.9 Amgen
5.9.1 Amgen Profile
5.9.2 Amgen Main Business
5.9.3 Amgen Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.9.4 Amgen Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.9.5 Amgen Recent Developments
5.10 Biogen
5.10.1 Biogen Profile
5.10.2 Biogen Main Business
5.10.3 Biogen Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.10.4 Biogen Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.10.5 Biogen Recent Developments
5.11 UCB
5.11.1 UCB Profile
5.11.2 UCB Main Business
5.11.3 UCB Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.11.4 UCB Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.11.5 UCB Recent Developments
5.12 Eli Lilly and Company
5.12.1 Eli Lilly and Company Profile
5.12.2 Eli Lilly and Company Main Business
5.12.3 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.12.4 Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.12.5 Eli Lilly and Company Recent Developments
5.13 AstraZeneca
5.13.1 AstraZeneca Profile
5.13.2 AstraZeneca Main Business
5.13.3 AstraZeneca Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
5.13.4 AstraZeneca Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) & (2024-2024)
5.13.5 AstraZeneca Recent Developments
6 North America
6.1 North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunoglobulin G Antibody Therapeutics Market Dynamics
11.1 Immunoglobulin G Antibody Therapeutics Industry Trends
11.2 Immunoglobulin G Antibody Therapeutics Market Drivers
11.3 Immunoglobulin G Antibody Therapeutics Market Challenges
11.4 Immunoglobulin G Antibody Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Immunoglobulin G Antibody Therapeutics Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Immunoglobulin G Antibody Therapeutics Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Immunoglobulin G Antibody Therapeutics Market Size Share by Region (2024-2024)
Table 4. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Immunoglobulin G Antibody Therapeutics Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2024)
Table 9. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Table 11. North America Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Immunoglobulin G Antibody Therapeutics Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2024)
Table 24. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Table 26. North America Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Immunoglobulin G Antibody Therapeutics Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Immunoglobulin G Antibody Therapeutics Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulin G Antibody Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Immunoglobulin G Antibody Therapeutics Market
Table 40. Global Immunoglobulin G Antibody Therapeutics Key Players Headquarters and Area Served
Table 41. Immunoglobulin G Antibody Therapeutics Product Solution and Service
Table 42. Global Immunoglobulin G Antibody Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Basic Information List
Table 45. Roche Description and Business Overview
Table 46. Roche Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Roche (2024-2024)
Table 48. Roche Recent Developments
Table 49. Abbvie Basic Information List
Table 50. Abbvie Description and Business Overview
Table 51. Abbvie Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Abbvie (2024-2024)
Table 53. Abbvie Recent Developments
Table 54. J & J Basic Information List
Table 55. J & J Description and Business Overview
Table 56. J & J Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of J & J (2024-2024)
Table 58. J & J Recent Developments
Table 59. Bristol-Myers Squibb Basic Information List
Table 60. Bristol-Myers Squibb Description and Business Overview
Table 61. Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Bristol-Myers Squibb (2024-2024)
Table 63. Bristol-Myers Squibb Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Novartis (2024-2024)
Table 68. Novartis Recent Developments
Table 69. Merck Basic Information List
Table 70. Merck Description and Business Overview
Table 71. Merck Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Merck (2024-2024)
Table 73. Merck Recent Developments
Table 74. Alexion Pharmaceuticals Basic Information List
Table 75. Alexion Pharmaceuticals Description and Business Overview
Table 76. Alexion Pharmaceuticals Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Alexion Pharmaceuticals (2024-2024)
Table 78. Alexion Pharmaceuticals Recent Developments
Table 79. Takeda Basic Information List
Table 80. Takeda Description and Business Overview
Table 81. Takeda Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Takeda (2024-2024)
Table 83. Takeda Recent Developments
Table 84. Amgen Basic Information List
Table 85. Amgen Description and Business Overview
Table 86. Amgen Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Amgen (2024-2024)
Table 88. Amgen Recent Developments
Table 89. Biogen Basic Information List
Table 90. Biogen Description and Business Overview
Table 91. Biogen Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Biogen (2024-2024)
Table 93. Biogen Recent Developments
Table 94. UCB Basic Information List
Table 95. UCB Description and Business Overview
Table 96. UCB Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of UCB (2024-2024)
Table 98. UCB Recent Developments
Table 99. Eli Lilly and Company Basic Information List
Table 100. Eli Lilly and Company Description and Business Overview
Table 101. Eli Lilly and Company Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of Eli Lilly and Company (2024-2024)
Table 103. Eli Lilly and Company Recent Developments
Table 104. AstraZeneca Basic Information List
Table 105. AstraZeneca Description and Business Overview
Table 106. AstraZeneca Immunoglobulin G Antibody Therapeutics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Immunoglobulin G Antibody Therapeutics Business of AstraZeneca (2024-2024)
Table 108. AstraZeneca Recent Developments
Table 109. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2024) & (US$ Million)
Table 110. North America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 111. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2024) & (US$ Million)
Table 112. Europe Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 113. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2024-2024) & (US$ Million)
Table 115. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 116. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Region (2024-2024)
Table 117. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Region (2024-2034)
Table 118. Latin America Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2024) & (US$ Million)
Table 120. Latin America Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 121. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 122. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2024) & (US$ Million)
Table 123. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 124. Immunoglobulin G Antibody Therapeutics Market Trends
Table 125. Immunoglobulin G Antibody Therapeutics Market Drivers
Table 126. Immunoglobulin G Antibody Therapeutics Market Challenges
Table 127. Immunoglobulin G Antibody Therapeutics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunoglobulin G Antibody Therapeutics Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Immunoglobulin G Antibody Therapeutics Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Immunoglobulin G Antibody Therapeutics Market Share by Regions: 2022 VS 2034
Figure 4. Global Immunoglobulin G Antibody Therapeutics Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of IgG1
Figure 11. Global IgG1 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of IgG4
Figure 13. Global IgG4 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Immunoglobulin G Antibody Therapeutics Market Size Share by Type: 2022 & 2034
Figure 17. North America Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Figure 18. Europe Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue Market Share by Type (2024-2034)
Figure 22. Autoimmune Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Tumor Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Immunoglobulin G Antibody Therapeutics Market Size Share by Application: 2022 & 2034
Figure 26. North America Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Figure 27. Europe Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Immunoglobulin G Antibody Therapeutics Revenue Market Share by Application (2024-2034)
Figure 31. Immunoglobulin G Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Immunoglobulin G Antibody Therapeutics Market Share in 2022
Figure 33. North America Immunoglobulin G Antibody Therapeutics Market Share by Country (2024-2034)
Figure 34. U.S. Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 37. France Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Immunoglobulin G Antibody Therapeutics Market Share by Region (2024-2034)
Figure 43. China Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 47. India Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Immunoglobulin G Antibody Therapeutics Market Share by Country (2024-2034)
Figure 50. Mexico Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Immunoglobulin G Antibody Therapeutics Market Share by Country (2024-2034)
Figure 53. Turkey Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Immunoglobulin G Antibody Therapeutics Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report